Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH).
Barré T, Rojas Rojas T, Lacombe K, Protopopescu C, Poizot-Martin I, Nishimwe ML, Zucman D, Esterle L, Billaud E, Aumaitre H, Bouchaud O, Rey D, Piroth L, Salmon-Ceron D, Wittkop L, Sogni P, Carrieri MP, Serfaty L, Marcellin F. Barré T, et al. Among authors: rey d. Expert Rev Anti Infect Ther. 2021 Sep;19(9):1147-1156. doi: 10.1080/14787210.2021.1884545. Epub 2021 Feb 22. Expert Rev Anti Infect Ther. 2021. PMID: 33538612
Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients.
Piroth L, Grappin M, Cuzin L, Mouton Y, Bouchard O, Raffi F, Rey D, Peyramond D, Gourdon F, Drobacheff C, Lombart ML, Lucht F, Besnier JM, Bernard L, Chavanet P, Portier H. Piroth L, et al. Among authors: rey d. J Viral Hepat. 2000 Jul;7(4):302-8. doi: 10.1046/j.1365-2893.2000.00227.x. J Viral Hepat. 2000. PMID: 10886541
Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study.
Sène D, Pol S, Piroth L, Goujard C, Dellamonica P, Moussali J, Rey D, Loustaud-Ratti V, Alric L, Chousterman M, Borsa-Lebas F, Boucher O, Séréni D, Cacoub P; GERMIVIC Study Group. Sène D, et al. Among authors: rey d. Epidemiol Infect. 2007 Apr;135(3):409-16. doi: 10.1017/S0950268806006947. Epub 2006 Jul 25. Epidemiol Infect. 2007. PMID: 16863601 Free PMC article.
Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.
Lang S, Mary-Krause M, Cotte L, Gilquin J, Partisani M, Simon A, Boccara F, Costagliola D; Clinical Epidemiology Group of the French Hospital Database on HIV. Lang S, et al. Arch Intern Med. 2010 Jul 26;170(14):1228-38. doi: 10.1001/archinternmed.2010.197. Arch Intern Med. 2010. PMID: 20660842
Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, Colin de Verdière N, Slama L, Martin K, Lortholary O, Carrat F; ANRS HB03 VIHVAC-B Trial. Launay O, et al. Among authors: rey d. JAMA. 2011 Apr 13;305(14):1432-40. doi: 10.1001/jama.2011.351. JAMA. 2011. PMID: 21486976 Clinical Trial.
Post-exposure prophylaxis for HIV infection.
Rey D. Rey D. Expert Rev Anti Infect Ther. 2011 Apr;9(4):431-42. doi: 10.1586/eri.11.20. Expert Rev Anti Infect Ther. 2011. PMID: 21504400 Review.
473 results